Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Neostigmine methylsulfate |
Is a |
False |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neostigmine measurement |
Component |
True |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Neostigmine adverse reaction (disorder) |
Causative agent (attribute) |
True |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to neostigmine (finding) |
Causative agent (attribute) |
False |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neostigmine [neuromuscular transmission] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prostigmin 2.5mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neostigmine+glycopyrronium 2.5mg/500micrograms/1mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neostigmine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing neostigmine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Neostigmine bromide (substance) |
Is a |
False |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing neostigmine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Neostigmine+glycopyrronium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prostigmin 2.5mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to neostigmine (finding) |
Causative agent (attribute) |
True |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Neostigmine methylsulfate |
Is modification of (attribute) |
True |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neostigmine bromide (substance) |
Is modification of (attribute) |
True |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycopyrronium- and neostigmine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glycopyrronium- and neostigmine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only neostigmine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only glycopyrronium and neostigmine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Neostigmine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only neostigmine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glycopyrronium and neostigmine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Neostigmine test (procedure) |
Direct substance |
True |
Neostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |